FLUAD

Product NDC
70461-019
11-digit product format
704610019
Labeler code
70461
Product ID
70461-019_97c3669d-ac04-4c97-b2ab-2ce4d0bf6e12
Type
VACCINE
Nonproprietary name
Influenza Vaccine, Adjuvanted
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Labeler
Seqirus, Inc.
Application
BLA125510
Marketing category
BLA
Marketing start
2015-11-24
Marketing end
2020-07-31
Substance
INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED)
Active strength
15 ug/.5mL; ug/.5mL; ug/.5mL
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct70461-019DDiscontinued by firm2026-07-31
excluded packagepackage70461-01970461-019-03DDiscontinued by firm2026-07-31

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70461-019-03ML - Milliliter70461-0199c7b3e36-329f-4c04-9971-c9d02be093e112019-08-06
70461-019-04ML - Milliliter70461-01905463ddb-1419-477a-805a-b209d081644812019-08-06

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125510FluadInfluenza Vaccine, Adjuvanted351(a)Disc2026-06-01